N-Power Medicine
PrivateLast Round
Series B
Sep 1, 2026
Total Funding Raised
$117M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
N-Power Medicine is a biotechnology company that provides an AI-enabled clinical research platform to accelerate oncology drug development by integrating research workflows into community oncology practices.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Precision Medicine, Data Integration, Healthcare Analytics
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
N-Power Medicine Comparables
Compare N-Power Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verana Health | 83% | |
| xCures | 81% | |
| Pi Health | 81% |
N-Power Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 1, 2026 | ||||
| Strategic | Dec 30, 2024 | ||||
| Series B | Jul 1, 2024 |
Key People
Founding team and executive leadership
N-Power Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovatus Capital Partners | Strategic, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
$32M round with Merck & Co., Inc. and Innovatus Capital Partners.
- Jul 26, 2026
Monthly visitors increased 87% MoM.
Recent news
Latest coverage and updates
- partners_withOct 8, 2026
N-Power Medicine, Inc. and New York Cancer partner to accelerate Prospective External Control Arms in community oncology, with New York Cancer joining the N-Power Network and offering programs to patients beginning in non-small cell lung cancer, on Oct 8th '26 in New York.
- receives_financingSep 1, 2026
N-Power Medicine, Inc. received financing of $32M in Series B on Sep 1st '26.
- is_developingAug 20, 2026
In Delaware, N-Power Medicine, Inc. and Bayhealth collaborate to develop a sustainable precision oncology and research program that integrates clinical and molecular data, technology, and multidisciplinary expertise.
N-Power Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about N-Power Medicine's valuation, stock price, and market status.
Is N-Power Medicine a public or private company?
N-Power Medicine is a private company.
What is the current stock price of N-Power Medicine?
N-Power Medicine is a private company, so its shares have no public market price. Caplight tracks N-Power Medicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is N-Power Medicine worth (valuation)?
Valuation information for N-Power Medicine is not publicly available.
Can I buy N-Power Medicine stock?
N-Power Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was N-Power Medicine's last funding round?
N-Power Medicine's most recent funding round was Series B on September 1, 2026.
Who are the main investors in N-Power Medicine?
Key investors in N-Power Medicine include Innovatus Capital Partners.
Will N-Power Medicine IPO soon?
No public IPO plans have been announced for N-Power Medicine.
How can I track N-Power Medicine secondary market activity?
Caplight tracks bids, offers, and trades in N-Power Medicine's shares on secondary markets.